Plasma viscosity in patients with metabolic syndrome

被引:4
作者
Ucak, Sema [1 ]
Basat, Okcan [2 ]
Cetinkaya, Emel [1 ]
机构
[1] Fatih Sultan Mehmet Res & Training Hosp, Dept Internal Med, Istanbul, Turkey
[2] Sisli Etfal Res & Training Hosp, Dept Internal Med, Div Endocrinol Metab & Diabet, Istanbul, Turkey
关键词
Plasma viscosity; metabolic syndrome; C-REACTIVE PROTEIN; INSULIN-RESISTANCE; BLOOD-VISCOSITY; CARDIOVASCULAR-DISEASE; HEMATOCRIT LEVELS; ALL-CAUSE; RISK; MORTALITY; SENSITIVITY; HYPERINSULINEMIA;
D O I
10.3233/CH-2012-1559
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
BACKGROUND AND AIM: Plasma viscosity, which is affected by plasma lipid and protein composition, is a hemorheological parameter accepted as an early cardiovascular risk factor. In this study we aimed to investigate the alterations in plasma viscosity in patients with metabolic syndrome since both are early predictors of CVD. MATERIAL AND METHODS: A total number of 70 patients aged between 25-55 years with the diagnosis of metabolic syndrome according to IDF 2005 criteria and 32 age and sex matched healthy subjects were allocated consecutively in the study. Body mass index (BMI), arterial blood pressure, blood glucose, total cholesterol, HDL and triglyceride levels were measured and plasma viscosity was measured. The results of patients with MS and healthy subjects were compared. Correlation between components of the Metabolic Syndrome and plasma viscosity was assessed. RESULTS: BMI, systolic and diastolic blood pressure, waist circumference, serum lipid and glucose levels and plasma viscosity levels were higher in patient group (p < 0.001). A positive correlation was determined between plasma viscosity and waist circumference, hypertension and serum lipid levels (r = 0.401, p = 0.003). CONCLUSION: Plasma viscosity is increased in patients with metabolic syndrome and it is associated with waist circumference, hypertension and plasma lipid levels.
引用
收藏
页码:15 / 22
页数:8
相关论文
共 36 条
[1]
Metabolic syndrome - a new world-wide definition. A consensus statement from the international diabetes federation [J].
Alberti, KGMM ;
Zimmet, P ;
Shaw, J .
DIABETIC MEDICINE, 2006, 23 (05) :469-480
[2]
Aloulou I, 2006, CLIN HEMORHEOL MICRO, V35, P113
[3]
Association Between Obesity, High-Sensitivity C-Reactive Protein ≥2 mg/L, and Subclinical Atherosclerosis Implications of JUPITER from the Multi-Ethnic Study of Atherosclerosis [J].
Blaha, Michael J. ;
Rivera, Juan J. ;
Budoff, Matthew J. ;
Blankstein, Ron ;
Agatston, Arthur ;
O'Leary, Daniel H. ;
Cushman, Mary ;
Lakoski, Susan ;
Criqui, Michael H. ;
Szklo, Moyses ;
Blumenthal, Roger S. ;
Nasir, Khurram .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2011, 31 (06) :1430-U422
[4]
Plasma viscosity and insulin resistance in metabolic syndrome [J].
Caimi, G ;
Sinagra, D ;
Scarpitta, AM ;
Lo Presti, R .
INTERNATIONAL JOURNAL OF OBESITY, 2001, 25 (12) :1856-1857
[5]
The effects of high haematocrit levels on glucose metabolism disorders [J].
Çapoglu, I ;
Ünüvar, N ;
Bektas, Y ;
Yilmaz, Ö ;
Kaya, MD .
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2002, 30 (04) :433-437
[6]
Relation between insulin resistance and hematological parameters in elderly Koreans - Southwest Seoul (SWS) Study [J].
Choi, KM ;
Lee, J ;
Kim, YH ;
Kim, KB ;
Kim, DL ;
Kim, SG ;
Shin, DH ;
Kim, NH ;
Park, IB ;
Choi, DS ;
Baik, SH .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2003, 60 (03) :205-212
[7]
Cortinovis A, 2006, CLIN HEMORHEOL MICRO, V35, P183
[8]
Haematocrit, viscosity, erythrocyte sedimentation rate: meta-analyses of prospective studies of coronary heart disease [J].
Danesh, J ;
Collins, R ;
Peto, R ;
Lowe, GDO .
EUROPEAN HEART JOURNAL, 2000, 21 (07) :515-520
[9]
Central Adiposity, Systemic Inflammation, and the Metabolic Syndrome [J].
Elks, Carrie M. ;
Francis, Joseph .
CURRENT HYPERTENSION REPORTS, 2010, 12 (02) :99-104
[10]
Erdem TY, 2008, CLIN HEMORHEOL MICRO, V38, P219